Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues0000000000000000000000000000
% growth12 %42 %18 %31 %27 %28 %28 %
EBITDA0000000000000000000000000000
% EBITDA margin(122 %)(168 %)(173 %)(99 %)(71 %)(43 %)(25 %)
Profit0000000000000000000000000000
% profit margin(139 %)(182 %)(184 %)(127 %)(82 %)(52 %)(35 %)
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue65 %66 %74 %59 %---

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor investor

$0.0

round
investor

$0.0

round
investor investor investor investor

$0.0

round
investor investor investor investor

$0.0

round
investor investor investor investor investor investor investor investor

$0.0

round
N/A

$0.0

Valuation: $0.0

40.1x EV/LTM Revenues

-32.9x EV/LTM EBITDA

round
*

$50.0m

Post IPO Debt
Total Funding000k

Recent News about Sophia Genetics

Edit
More about Sophia Geneticsinfo icon
Edit

Sophia Genetics is a healthcare analytics startup that operates in the field of data-driven medicine. The company's primary offering is the SOPHiA DDM™ Platform, a cloud-based system powered by artificial intelligence (AI) and machine learning (ML). This platform allows healthcare providers to standardize, compute, and analyze digital health data, generating insights that can improve diagnosis, therapy selection, analysis, and drug development.

Sophia Genetics serves a wide range of customers, including hospitals, research institutions, and pharmaceutical companies. These customers perform testing on their own samples, retain ownership of their data, and use the SOPHiA DDM™ Platform to analyze this data. They can also share their insights with each other, contributing to a collective intelligence that can improve patient outcomes worldwide.

The company operates in a global market, with a particular focus on genomic profiling. This involves analyzing a patient's genetic information to understand their susceptibility to certain diseases, such as cancer or inherited disorders. The SOPHiA DDM™ Platform can analyze complex multimodal data sets, which means it can handle different types of data at the same time.

Sophia Genetics makes money by charging its customers for access to the SOPHiA DDM™ Platform. This business model allows the company to generate revenue while also contributing to the democratization of data-driven medicine.

Keywords: Healthcare Analytics, Data-Driven Medicine, Genomic Profiling, Artificial Intelligence, Machine Learning, Cloud-Based Platform, Digital Health Data, Collective Intelligence, Global Market, Business Model.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Sophia Genetics

Edit
Interactive Biosoftware
ACQUISITION by Sophia Genetics Jun 2018